Bond Bristol Myers-Squibb 3.25% ( US110122BB30 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price | |
| Country | United States
|
| ISIN code |
US110122BB30 ( in USD )
|
| Interest rate | 3.25% per year ( payment 2 times a year) |
| Maturity | 27/02/2027 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 750 000 000 USD |
| Cusip | 110122BB3 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 27/02/2026 ( In 18 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's US$750,000,000 3.25% bonds (CUSIP: 110122BB3, ISIN: US110122BB30) maturing February 27, 2027, currently trade at 97.64% of face value, with a minimum trading size of 2,000 bonds, paying semi-annual coupons, and are rated A by S&P and A2 by Moody's. |
Français
Italiano
United States